Table 2.

Characteristics of 3 patients in whom mean left ventricular wall thickness decreased by 2 mm or more and NT-proBNP decreased by 30% or more after chemotherapy




FLC, mg/L


NT-proBNP, ng/L

Mean VWT, mm

NYHA class
Patient no.
FLC type
Pre-Tx
Post-Tx
CR
Pre-Tx
Post-Tx
Pre-Tx
Post-Tx
Pre-Tx
Post-Tx
1   λ   248.0   68.6   No   861   174   19   14   II   I  
2   λ   140.0   5.3   Yes   6 097   1052   21   18   III   I  
3
 
κ
 
129.0
 
1.7
 
Yes
 
10 447
 
2746
 
16
 
13
 
III
 
I
 



FLC, mg/L


NT-proBNP, ng/L

Mean VWT, mm

NYHA class
Patient no.
FLC type
Pre-Tx
Post-Tx
CR
Pre-Tx
Post-Tx
Pre-Tx
Post-Tx
Pre-Tx
Post-Tx
1   λ   248.0   68.6   No   861   174   19   14   II   I  
2   λ   140.0   5.3   Yes   6 097   1052   21   18   III   I  
3
 
κ
 
129.0
 
1.7
 
Yes
 
10 447
 
2746
 
16
 
13
 
III
 
I
 

Pre-Tx indicates before therapy; Post-Tx, after therapy; CR, complete remission at immunofixation; and VWT, ventricular-wall thickness.

Close Modal

or Create an Account

Close Modal
Close Modal